Author

T. Zitman-Gal

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Association of SGLT2 inhibitors and GLP-1 receptor agonists with mortality and renal outcomes in patients with diabetes and chronic kidney disease: the diabetic nephropathy management and outcome (DINAMO) study

Patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) are at high risk for kidney failure and death. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) improve cardiovascular and renal outcomes; yet, their real-world use in patients with diabe...

K. Cohen-Hagai, T. Zitman-Gal, Kalantar-Zadeh Kamyar et al. · Cardiovascular Diabetology · 0 citations

Open access Sep 2026

Endothelial-Fibroblast Organoids Generated in Hydrogel Microchamber Arrays: A Translational Model of Vascular Dysfunction in Cardio-Kidney-Metabolic Disease.

Cardio-kidney-metabolic disease comprises interconnected cardiovascular, renal, and metabolic disorders in which endothelial dysfunction drives microvascular and macrovascular injury. Although novel treatments improve clinical outcomes, the cellular and molecular mechanisms underlying these effects remain incompletely...

T. Zitman-Gal, M. Sobolev, Anna Talash et al. · Journal of Vascular Research · 0 citations